Cryopreservation – News and Features

A study analyzed genetic data from over 1,400 men with testicular germ cell tumors (TGCTs) and 18,000 cancer-free controls. The findings suggest a link between TGCT risk and genetic variants affecting cell movement and shape.

Learn how population genomics has evolved, its role in health and disease and the challenges ahead.

Research from the University of Cambridge shows that metformin, a widely used and affordable diabetes drug, could prevent a form of acute myeloid leukaemia in people at high risk of the disease.

A study led by Northwestern Medicine used CRISPR interference to identify Commander proteins involved in Parkinson’s disease risk. These proteins play a key role in lysosomal function, and targeting them could offer new therapeutic options.

A repurposed anti-cancer drug, Cilengitide, was found to reduce kidney scarring and slow disease progression in preclinical models, suggesting a possible precision medicine approach for high-risk patients.

Explore how proteomics, AI and microsampling are advancing biomarker discovery. Learn how these innovations are shaping the future of precision medicine.

The limitations of traditional cryopreservation are becoming increasingly apparent. In this interview, Alastair Carrington, CEO of Atelerix, explores how hypothermic preservation technology is transforming biopreservation.

The brain's cholesterol regulation and metabolism mechanisms may make some neurons more vulnerable to damage in the early stages of Alzheimer's disease.

A cohort study of 85,000 adults found that engaging in light and moderate physical activity daily lowers cancer risk. Participants who replaced sedentary time with physical activity had a reduced risk of developing cancer.

With 23andMe filing for bankruptcy, customers worry about their genetic data. Learn what experts say about privacy and data protection.